reported the use of trichostatin A, a HDAC inhibitor, to downregulate HIF-1 and hypoxia-induced angiogenesis in an in vivo Lewis lung carcinoma model (50). This evidence concerns the gene HDAC9 and Carcinoma, Lewis Lung.